Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for MDT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
July 31, 2026 -1.619B
April 30, 2026 -917.00M
January 31, 2026 -816.00M
October 31, 2025 -482.00M
July 31, 2025 -719.00M
April 30, 2025 -490.00M
January 31, 2025 -843.00M
October 31, 2024 -345.00M
July 31, 2024 -259.00M
April 30, 2024 -696.00M
January 31, 2024 -707.00M
October 31, 2023 -424.00M
July 31, 2023 -539.00M
April 30, 2023 -475.00M
January 31, 2023 -287.00M
October 31, 2022 -1.146B
July 31, 2022 -1.585B
April 30, 2022 271.00M
January 31, 2022 -437.00M
October 31, 2021 -709.00M
July 31, 2021 -784.00M
April 30, 2021 1.919B
January 31, 2021 -2.773B
October 31, 2020 -2.02B
July 31, 2020 8.00M
Date Value
April 30, 2020 365.00M
January 31, 2020 -1.801B
October 31, 2019 -1.216B
July 31, 2019 -551.00M
April 30, 2019 -529.00M
January 31, 2019 -1.009B
October 31, 2018 121.00M
July 31, 2018 643.00M
April 30, 2018 111.00M
January 31, 2018 -378.00M
October 31, 2017 6.042B
July 31, 2017 83.00M
April 30, 2017 -272.00M
January 31, 2017 -942.00M
October 31, 2016 -73.00M
July 31, 2016 -284.00M
April 30, 2016 4.573B
January 31, 2016 -254.00M
October 31, 2015 -1.088B
July 31, 2015 -986.00M
April 30, 2015 -15.22B
January 31, 2015 -690.00M
October 31, 2014 -1.147B
July 31, 2014 -6.00M
April 30, 2014 -525.00M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
STERIS Plc (Ireland) -108.50M
Abbott Laboratories -673.00M
Becton, Dickinson & Co. -228.00M
Boston Scientific Corp. -1.956B
Intuitive Surgical, Inc. -26.60M